Vitamin D and Probability of Developmental Disorders among Perinatally HIV-Affected and Unaffected Ugandan Children
Related Experiment Video
Updated: Jul 23, 2025

Isolation of Leukocytes from Human Breast Milk for Use in an Antibody-dependent Cellular Phagocytosis Assay of HIV Targets
Published on: September 6, 2019
Jorem E Awadu1, Bruno Giordani2, Alla Sikorskii1
1Department of Psychiatry, Michigan State University, East Lansing, MI 48823, USA.
Insights
Vitamin D deficiency (VDD) is linked to increased developmental disorder risks in pre-adolescent children, particularly those with perinatal HIV infection. This association was not observed in adolescents, highlighting a developmental stage-dependent effect.
Area of Science:
- Pediatrics
- Nutritional Science
- Infectious Diseases
Background:
- Vitamin D deficiency (VDD) is a global health concern with potential impacts on child development.
- Children with perinatal HIV infection (CPHIV) may be at higher risk for nutritional deficiencies and developmental disorders.
- Understanding the interplay between vitamin D status, HIV exposure, and neurodevelopment is crucial for targeted interventions.
Purpose of the Study:
- To investigate the association between vitamin D deficiency (VDD) and the probability of developmental disorders in children.
- To examine if this association differs based on HIV status (CPHIV, CHEU, CHUU) and developmental stage (pre-adolescent vs. adolescent).
Main Methods:
- A longitudinal study involving 604 children (6-18 years) across three groups: CPHIV, HIV-exposed uninfected (CHEU), and HIV-unexposed uninfected (CHUU).
- Serum 25-hydroxyvitamin-D (25OHD) levels were measured to categorize vitamin D status (VDD, VDI, VDS).
- Developmental outcomes (autism, ADHD, EBD, functional impairment, resiliency) were assessed using caregiver reports (BASC-3) at baseline and 12-month follow-up.
Main Results:
- Baseline VDD was associated with a higher probability of autism spectrum disorder (ASD), attention deficit & hyperactivity (ADHD), and emotional behavioral disorder (EBD) in pre-adolescents.
- VDD also predicted higher functional impairment (FI) scores in pre-adolescents, with moderate clinical importance.
- No significant association between VDD and developmental disorders or resiliency was found in adolescents, indicating a developmental stage-dependent effect.
Conclusions:
- Vitamin D deficiency is associated with increased risks for specific developmental disorders and functional impairment in pre-adolescent children.
- The observed relationship is dependent on developmental stage, with no significant links found in adolescents.
- Further research is needed to elucidate this relationship and inform targeted interventions for at-risk pediatric populations.
Abstract:
We tested the hypothesis that vitamin D deficiency (VDD) is associated with higher developmental disorder probability in 604 children with perinatal HIV infection (CPHIV, n = 199), HIV exposed and uninfected (CHEU, n = 196), and HIV unexposed uninfected (CHUU, n = 201). Children at 6-18 years old and their adult caregivers were assessed at enrollment, 6, and 12-month follow-ups. Serum 25-hydroxyvitamin-D (25OHD) levels in children quantified per the NHANES protocol were used to define VD categories as VDD (25OHD < 20 ng/mL), VD insufficient (VDI, 20 ≤ 25OHD ≤ 25 ng/mL), and VD sufficient (VDS = reference group if 25OHD > 25 ng/mL). Perinatal HIV status per DNA polymerase chain reaction/HIV rapid diagnostic tests included: CPHIV, CHEU, and CHUU. Developmental stage was defined as pre-adolescent (age < 11) vs. adolescent (age ≥ 11) years. Caregiver responses to standardized questions from Behavioral Assessment System for Children, Third Edition (BASC-3), were used to calculate probability scores for four disorders, namely: autism (ASD), attention deficit & hyperactivity (ADHD), emotional behavioral disorder (EBD), functional impairment (FI), and resiliency at 0, 6 and 12 months. Multivariable longitudinal models estimated VD-associated standardized mean difference (SMD) and corresponding 95% confidence intervals (95% CI) in respective probability scores in Statistical Analysis Software (v.9.4). Baseline VDD vs. VDS predicted higher probability scores of moderate clinical importance for ASD, ADHD, EBD, and higher FI among pre-adolescents (SMD = 0.32 to 0.40, 95% CI: 0.00 to 0.74). VDD was not associated with resiliency or any developmental disorders among adolescents. VDD predicted higher developmental disorder and FI scores over 12 months in a developmental stage-dependent manner. This relationship requires further understanding to appropriately target future interventions.
Related Concept Videos
Immunodeficiency Diseases
There are three main causes of immunodeficiency...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Role of Skin in Vitamin D Synthesis
The solar UV B rays (290-315 nm) are absorbed by the skin, and 7-dehydrocholesterol (provitamin D3) photolyzes it to previtamin D3, which undergoes a rapid transformation to vitamin...
Vitamins
Role of Vitamins in Maintaining Bone Health
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...
Development of Immunocompetence
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...

